In this video, Anat Loewenstein, MD, MHA, highlights some of the most interesting points of a symposium on remote monitoring of retinal diseases, held during the virtual Euretina congress.
Remote monitoring will be needed even more now because longer-acting drugs are becoming available. “Although we have treatments that work long term, not for every patient we can allow long intervals between treatments, and these patients need to be monitored,” she said.